Trial
NCT05231668
Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
—
Condition
Osteogenesis Imperfecta
Intervention
SAR439459
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-11